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Abstract
Background: Interventions to improve medication adherence are diverse and complex. Consequently, synthesizing
this evidence is challenging. We aimed to extend the results from an existing systematic review of interventions to
improve medication adherence by using qualitative comparative analysis (QCA) to identify necessary or sufficient
configurations of behavior change techniques among effective interventions.
Methods: We used data from 60 studies in a completed systematic review to examine the combinations of nine
behavior change techniques (increasing knowledge, increasing awareness, changing attitude, increasing self-efficacy,
increasing intention formation, increasing action control, facilitation, increasing maintenance support, and motivational
interviewing) among studies demonstrating improvements in adherence.
Results: Among the 60 studies, 34 demonstrated improved medication adherence. Among effective studies,
increasing patient knowledge was a necessary but not sufficient technique. We identified seven configurations of
behavior change techniques sufficient for improving adherence, which together accounted for 26 (76 %) of the
effective studies. The intervention configuration that included increasing knowledge and self-efficacy was the
most empirically relevant, accounting for 17 studies (50 %) and uniquely accounting for 15 (44 %).
Conclusions: This analysis extends the completed review findings by identifying multiple combinations of behavior
change techniques that improve adherence. Our findings offer direction for policy makers, practitioners, and future
comparative effectiveness research on improving adherence.
Keywords: Medication adherence, Qualitative comparative analysis, Behavior change, Systematic review
Background
Medication adherence is a complex behavior with
multiple determinants that vary among individuals.
Although there is only one way for patients to be per-
fectly adherent, there are many ways that patients can
be nonadherent, such as missing doses, taking doses
late, taking fewer pills at each dose, or stopping a regi-
men early. Poor medication adherence is associated
with increased morbidity, mortality, and costs across a
range of clinical conditions [1]. The World Health
Organization estimated that adherence to long-term
therapy for chronic conditions is 50 % in developed
countries and even lower in developing countries [2].
The importance of medication adherence and the vari-
ability in nonadherence illustrates the need for
methods that can pinpoint specific and effective inter-
vention components to enhance adherence.
Similar to other health behaviors, interventions to im-
prove medication adherence are diverse and complex and
often use combinations of behavior change techniques
(BCTs), for example, techniques to increase self-efficacy
or change attitudes. Some members of our study team
[M.V., C.G] recently completed an Agency for Health-
care Quality and Research (AHRQ)-sponsored review* Correspondence: lkahwati@rti.org
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of interventions to improve medication adherence
among outpatients prescribed long-term medication
therapy for chronic conditions [3, 4]. This review,
which included 67 studies overall, synthesized findings
first by clinical condition and then by intervention type,
such as case management, self-management support,
collaborative care, or patient education, resulting in 40
different strength of evidence grades for each small
group of studies that used the same intervention type
among a study population defined by clinical condition.
Heterogeneity among the included studies precluded
quantitative synthesis (i.e., meta-analysis). The most
consistent evidence of improvement in medication ad-
herence across clinical conditions was for interventions
that included case management and educational inter-
ventions. Within clinical conditions, the strongest sup-
port was found for self-management of medications for
short-term improvement in adherence for asthma pa-
tients; collaborative care or case management programs
for short-term improvement of adherence and to im-
prove symptoms for patients taking depression medica-
tions; and pharmacist-led approaches for hypertensive
patients to improve systolic blood pressure. However,
this synthesis did not evaluate the effectiveness of the
various BCTs used across this body of evidence.
Interest is emerging in the use of qualitative comparative
analysis (QCA) within systematic reviews of complex in-
terventions because of the significant clinical heterogeneity
faced when trying to synthesize such evidence [5]. QCA
originates from the comparative social sciences to study
complex phenomena. QCA uses set theory—a branch of
mathematical logic that studies the properties of sets,
which are well-defined collections of objects—to examine
relationships between configurations of conditions (c.f., ex-
planatory variables) and an outcome. QCA is a non-
probabilistic method that may be useful for identifying
complex causal patterns that variable-oriented methods
may miss and it is an approach that may capitalize on the
heterogeneity within reviews that typically limits quantita-
tive synthesis [6–9]. Relationships of necessity (an explana-
tory variable or combination of variables is always present
when the outcome is present) and sufficiency (the out-
come is always present when the explanatory variable or
combination of variables is present) are two examples of
complex causal patterns that QCA can be used to identify.
For medication adherence interventions, QCA offers a
novel way to make sense of the underlying variation in
population, intervention components, and context and re-
lationship to intervention effectiveness.
In the present paper, we present findings from our use
of QCA to identify the combinations (i.e., configura-
tions) of patient-directed BCTs that were necessary or
sufficient, or both, for improving medication adherence
across the diverse body of evidence in the AHRQ review
previously completed by members of our study team.
This analysis was part of a larger study to examine the
suitability of using QCA within a systematic review con-
text. We expected that using QCA could elucidate com-
binations of patient-directed BCTs that, in turn, could
inform both current practice and intervention design for
future comparative effectiveness research.
Methods
We describe our approach to using QCA within the
completed AHRQ systematic review in a companion
article and figure also published in this issue [10].
The companion article provides a more in-depth dis-
cussion of the method, a simple hypothetical example
and glossary of terms commonly used in reporting
this method, and discussion of how this method can
be applied within a systematic review context. We ap-
plied existing standards of practice for conducting
QCA, though methods are evolving as with any rela-
tively novel method [11].
Case identification
We used the studies in the completed AHRQ systematic
review of interventions to improve medication adher-
ence as cases. The completed review was conducted by
members of our study team using methods associated
with the AHRQ Effective Health Care Program (available
at http://www.ncbi.nlm.nih.gov/books/NBK47095/), and
results from this review were published as an evidence
report and summarized in a peer-reviewed journal-
length article [3, 4]. This review was limited to studies
in the USA in adults with chronic conditions, exclud-
ing HIV/AIDS, severe mental illness, and substance
abuse. Studies were included if they intended to im-
prove adherence with self-administered, prescribed
medication; example interventions included patient
education, counseling, behavioral interventions, case
management, reminders, and shared decision-making.
The completed review included a total of 67 studies,
but we excluded 5 studies from the QCA that evaluated
policy-level interventions (e.g., copayment elimination)
because these studies lacked patient-directed BCTs. We
also excluded 2 other studies; one that did not include any
patient-directed element and one that evaluated an inter-
vention involving medication packaging because it was
too dissimilar from BCTs included in all of the other stud-
ies [12, 13]. Consequently, we included 60 studies, all
randomized controlled trials assessed as having low or
medium risk of bias, as cases in the QCA.
Outcome set calibration and set membership value
assignment
We specified that a study would be included in the out-
come set if the intervention group demonstrated an
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improvement in medication adherence. Studies in the re-
view used a variety of adherence outcomes measured at
various time points based on self-report, prescription
fills and refills, or medication event monitoring systems
(e.g., medication bottles with a microchip that registers
the date and time of every bottle opening). In the ab-
sence of a common outcome used across all studies, we
considered studies for which the intervention group
demonstrated statistically significant improvements on
at least one measure of adherence as compared with a
usual care group to be fully “in” the outcome set of ef-
fective studies (set membership value of “1.”). Studies
without improvement on at least one adherence out-
come were assigned as fully “out” of the set of effective
studies (set membership value of “0.”).
Condition set calibration and set membership value
assignment
We specified nine BCT condition sets and defined that a
study would be included in each BCT set based on
whether or not the specified BCT was a feature of the
study intervention. The BCTs specified for abstraction in
the completed review were derived from an existing
meta-analysis of medication adherence interventions and
a published taxonomy of BCTs [14, 15]. The nine BCTs
we included in the QCA were techniques to increase
knowledge, awareness, self-efficacy, intention formation,
techniques to influence action control, attitude, mainten-
ance; or were techniques that used facilitation, or motiv-
ational interviewing strategies. A brief description of
each BCT is in Table 1. Although the completed review
abstracted data for 12 BCTs, we did not include 3
BCTs—social influence, contingent reward, and stress
management—in the QCA because they were infre-
quently used.
During the review process, each study was evaluated
to identify whether or not it used each of the BCTs of
interest based on information provided in the article and
standard definitions of each BCT compiled by the review
team. Abstracted data from these studies could indicate
that a study used more than one BCT. We used this in-
formation abstracted during the review to determine
whether or not a BCT was a feature of the study inter-
vention for the QCA. For each of the BCT sets, we
assigned a set membership value of “1” if the study used
the BCT and assigned a set membership value of “0” if
the study did not use the BCT or if it was coded as “un-
clear” by the study abstractors.
Analysis
Because we calibrated sets dichotomously, we used
crisp-set QCA. Using Stata Release 13 (StataCorp, Col-
lege Station, TX), we generated 2 × 2 contingency tables
using each BCT and outcome set membership values to
identify individually necessary and sufficient BCTs for
the outcome of improved medication adherence. A
BCT is considered necessary if it is consistently present
as a feature of studies demonstrating improved adher-
ence, whereas a BCT is considered sufficient if im-
proved medication adherence is consistently present
when the BCT is present. We used a consistency
threshold of 90 % for necessity and 80 % for sufficiency
in our analyses.
Next, we used BCT set and outcome set membership
values assigned to create a truth table, which is the ana-
lytic device used in QCA to evaluate the necessity and
sufficiency of configurations of BCTs. A truth table in-
cludes all 2k logically possible configurations of condi-
tion set membership values, where k is equal to the
number of condition sets included in the analysis. Our
analysis with nine BCT sets generates a truth table with
512 rows, and we assigned each study in our analysis to
the truth table row that represented its configuration of
BCT set membership values. We then determined the
consistency for the truth table row based on the out-
come set membership values for the studies in the row.
If the proportion of studies within a truth table row
demonstrating improved adherence is above the speci-
fied consistency threshold (80 % in our analysis), the
Table 1 Behavior change techniques (BCTs) used in




Knowledge (K) General information about behavior-related
health consequences, use of individualized
information, increase in understanding/
memory enhancement
Awareness (R) Risk communication, self-monitoring,
reflective listening, behavioral feedback
Attitudes (T) Targets attitudes toward behavior
Self-efficacy (S) Modeling, practice/skills training, verbal
persuasion, coping response, graded tasks,
reattribution of success/failure
Intention formation (I) General intention, medication schedule,
goals, behavioral contract
Action control (C) Cues/reminders, self-persuasion, social
support
Maintenance (M) Maintenance goals, relapse prevention
Facilitation (F) Ongoing professional support, dealing with
adverse effects, individualizing/simplifying
regimen (fewer pills, fewer medications,
less frequent dosing, timing of dosing to




Client-centered yet directive counseling
style that facilitates behavior change
through helping clients resolve
ambivalence.
aAbbreviations in parentheses are used in the presentation of results
in Table 3
Kahwati et al. Systematic Reviews  (2016) 5:83 Page 3 of 9
outcome value for that row is assigned a value of “1”; all
other rows are assigned a value of “0.”
Each row with an outcome set value of “1” represents
a sufficient configuration of BCTs for the outcome of
improved adherence. We used fsQCA version 2.5 to per-
form logical minimization of sufficient truth table rows
and to calculate parameters of fit (consistency, raw
coverage, unique coverage) [16]. Lastly, we informed our
interpretation of the QCA solutions generated by exam-
ining how they were represented both within single
studies and across studies.
Results
Individually necessary and sufficient BCTs
Among the 60 studies, 34 demonstrated improved
medication adherence. Among these studies, no indi-
vidual BCT was both necessary (a BCT that is always
present when the outcome is present) and sufficient
(outcome always present when the BCT is present)
for improved medication adherence. Increasing know-
ledge was the only necessary individual BCT for im-
proved adherence; it was present in 31 of the 34
studies (consistency 91 %). No other individual BCT
was near the threshold for necessity (Table 2). Two
BCTs were identified as individually sufficient: enhan-
cing self-efficacy (consistency 90 %) and improving at-
titude (consistency 83 %). Another BCT, motivational
interviewing (consistency 78 %), was close to the
consistency threshold. A detailed discussion of
consistency is provided in the companion article in
this issue [10].
Sufficient configurations of BCTs and solutions
We identified 37 unique configurations of BCTs (i.e.,
truth table rows) present among the 60 studies; this rep-
resents 7 % of the 512 truth table rows comprising all
logically possible configurations. Of these 37 rows, 19
had a consistency higher than our specified threshold
(80 %) for the outcome of improved medication adher-
ence; these rows were used for subsequent truth table
analyses. The rows not used included 14 that had an
outcome value of “0” for improved medication adher-
ence, and 4 that were contradictory, with outcome
consistency ranging from 33 to 50 %. The rows without
any empirical cases are referred to as logical remainders
and were used in generating results as described in the
next paragraph. The truth table is provided in the online
supplementary material (Additional file 1: Appendix A).
Findings from the logical minimization of the truth table
are presented as solutions. The complex solution—the so-
lution that makes no simplifying assumptions about lo-
gical remainders—identified 14 sufficient configurations of
BCTs within studies demonstrating improved medication
adherence. The parsimonious solution—the solution gen-
erated automatically by the software using simplifying as-
sumptions about logical remainders to achieve the most
parsimonious results without evaluating the plausibility of
those assumptions—identified 5 sufficient configurations.
The intermediate solution—the solution generated using
researcher knowledge and expectations to guide the sim-
plifying assumptions made by the software—identified 7
sufficient configurations. We present the intermediate so-
lution as our main finding because we believe that some
of the simplifying assumptions made to achieve maximum






Number of studies with
BCT
Number of studies with BCT
from among those studies
demonstrating improved
adherence (N = 34)b
Of studies demonstrating
improved adherence (N = 34)b,
percent with BCT
Of studies with BCT, percent
that demonstrate improved
adherence
Knowledge (K) 53 31 91 % 58 %
Facilitation (F) 32 16 47 % 50 %
Awareness (R) 29 15 44 % 52 %
Self-efficacy (S) 20 18 53 % 90 %
Intention formation (I) 14 9 26 % 64 %
Action control (C) 10 5 15 % 50 %
Attitude (T) 12 10 29 % 83 %
Maintenance (M) 9 5 15 % 56 %
Motivational interviewing
(G)
9 7 21 % 78 %
aAbbreviations used in parentheses are used in the presentation of results in Table 3
b34 studies demonstrated improved medication adherence out of a total of 60 used for this analysis
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parsimony are substantively implausible. Additional detail
about the parsimonious and complex solutions and add-
itional analyses related to identifying configurations of
BCTs in studies without improvements in medication ad-
herence are provided in the online supplementary material
(Additional file 1: Appendix B and C, respectively).
The intermediate solution and its parameters of fit are
detailed in Table 3. In this table, sufficient configurations
of BCTs are represented by single letter abbreviations
where uppercase notation represents the presence of the
BCT and lowercase notation represents the absence of
the BCT. The solution consistency was 100 %, and solu-
tion coverage was 76 %, with 26 of the 34 effective stud-
ies accounted for. Three studies were covered by more
than one BCT configuration and five of the configura-
tions uniquely covered at least one study. The BCT con-
figuration consisting of increasing knowledge AND
enhancing self-efficacy (“KS”) covered half of the studies
demonstrating improved medication adherence (17
studies, raw coverage 50 %) and uniquely covered all but
two of those studies (unique coverage 44 %). The other
six configurations had raw coverage ranging from one
study (3 %) to four studies (12 %). We tested different
consistency thresholds between 70 and 90 % and did not
find any differences in the results (not shown).
Representation of solutions within and across studies
The remainder of the results section relates the configu-
rations we identified back to the specific studies in-
cluded in the review to provide examples of how these
configurations were represented within the studies. Any
individual study covered by a particular configuration
may or may not contain other BCTs not explicitly identi-
fied by an uppercase or lowercase notation in the solu-
tion term. Because the minimization process removes
logically redundant terms, the final solutions do not con-
tain a term for all nine BCTs. For example, the set of
studies covered by the configuration of “KS” all contain
Table 3 Intermediate solution for configurations of behavior change techniques (BCTs) used in effective interventions to improve
medication adherence
Solution parameters
Consistencya: 100 % (34 studies)
Coverageb: 76 % total (26 studies)
68 % unique (23 studies)
8 % overlapping (3 studies)
Truth table rows covered: 7.2 % (37 of 512 rows)
Number of studies with outcome not coveredc: 8
Bender et al. 2010 [46], Hoffman et al. 2003 [47], Lee et al. 2006 [48],
Okeke et al. 2009 [49], Ross et al. 2004 [50], Smith et al. 2008 [51],










KS 100 50 (17) 44 (15) eBerg et al. 1997 [24], eJanson et al. 2003 [18], eJanson et al. 2009 [17],
eJohnson et al. 2006a [29], eJohnson et al, 2006b [28], eKaton et al. 1995 [26],
eKaton et al. 1999/Katon et al. 2002 [25], eKaton et al. 1996 [21],
Katon et al. 2001/Ludman et al. 2003/Van Korff et al. 2003 [22],
eMurray et al. 2007 [23], Ogedegbe et al. 2012 [54], eRudd et al. 2004 [19],
eSchaffer et al. 2004 [33], eSimon et al. 2004 [30], eStacy et al. 2009 [32],
eWilson et al. 2010 [20], eWu et al. 2012 [31]
fG 100 12 (4) 6 (2) eBerger et al. 2005 [35], eFriedman et al. 1996 [34], Katon et al. 2001 [22],
Ogedegbe et al. 2012 [54]
rSIT 100 6 (2) 0 (0) Ogedegbe et al. 2012 [54], Wolever et al. 2010 [55]
kfCm 100 3 (1) 3 (1) eFulmer et al. 1999 [43]
fSmIT 100 6 (2) 0 (0) Ogedegbe et al. 2012 [54], Wolever et al. 2010 [55]
KRFICm 100 6 (2) 6 (2) eBosworth et al. 2008 [37], eRich et al. 1996 [38]
KrFT 100 9 (3) 9 (3) eBogner et al. 2012 [40], eBogner et al. 2010 [39], eBogner et al. 2008 [41]
aConsistency is determined by dividing the number of studies in the outcome set that are covered by the configuration by the number of studies covered by the
configuration. Consistency can range from 0 to 100 %. A consistency of 100 % indicates that all studies covered by the configuration are also in the outcome set
(i.e., had improved adherence)
bTotal coverage is determined by dividing the number of studies covered by any sufficient configuration in the solution by the number of studies demonstrating
improved adherence. Unique coverage is determined by dividing the number of studies that are only covered by one of the sufficient configurations by the total
number of studies demonstrating improved adherence. Total and unique coverage can range from 0 to 100 %. Overlapping coverage is the difference between
total and unique coverage
cStudies with the outcome that are not covered by a configuration (i.e., unexplained cases) are studies that were located in contradictory rows. In this study, we
identified four contradictory rows where some studies covered by the configuration demonstrated improved medication adherence, and others studies covered
by the same configuration did not demonstrate improvements in adherence. The studies listed here are those that were associated with improved adherence in
those rows
dAn uppercase letter in the configuration indicates the BCT was used as part of the study intervention; a lowercase letter indicates that the BCT was not used as
part of the study intervention. BCTs not listed with either an uppercase or lowercase letter in a configuration were eliminated during the process of
logical minimization
eStudy is uniquely covered by the indicated configuration
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an intervention component to increase knowledge AND
a component to enhance self-efficacy, but any one indi-
vidual study covered by “KS” may or may not also con-
tain components targeting awareness, attitude, intention
formation, action control, maintenance, facilitation, and
motivation, all of which “fell out” during the
minimization process because their presence or their ab-
sence was inconsistently associated with the outcome of
improved adherence.
The most empirically relevant configuration we identi-
fied was “KS”; studies covered by this configuration in-
cluded intervention components to increase knowledge
AND to enhance self-efficacy. The 17 studies covered by
the “KS” configuration spanned six different clinical con-
ditions (hypertension, depression, diabetes, asthma, con-
gestive heart failure, and hyperlipidemia); all but one
targeted only a single chronic condition. “KS” interven-
tions were delivered in-person or by telephone, and also
included interventions that were automated, such as the
use of computer-generated feedback or mailed educa-
tional information. This configuration included several
clusters of studies by the same author or research team,
though using different study populations. The know-
ledge component of the “KS” configuration was similar
across these 17 studies and was exemplified through a
variety of intervention components designed to increase
patient knowledge on disease facts (prevalence, symp-
toms, triggers, pathophysiology), medications available
for treatment and side effects of medications, and short-
or long-term adverse consequences of poor adherence
or no treatment at all.
In the 17 “KS” studies, knowledge components were
coupled with techniques to raise self-efficacy, specifically
information and skills needed to overcome barriers to
adherence, although the specific self-efficacy techniques
used by study interventions varied. These techniques in-
cluded skills training [17–21], problem solving skills and
coping skills [21, 22], and counseling or aids to enhance
self-management behaviors and increase self-efficacy to
self-manage [22–26]. Some of the studies used theory-
based interventions; for example, a highly structured de-
pression treatment program used brief psychotherapy
based on Bandura’s social cognitive theory and several
social learning theories [21]. Several interventions were
based on the transtheoretical model [27]; two of these
studies by the same author included stage-matched,
computer-generated information reports based on par-
ticipant responses to a baseline assessment [28, 29].
Similarly, one study used telephone care managers com-
bined with a workbook designed for behavioral activa-
tion to support long-term self-management and self-care
for patients with depression; the self-efficacy component
is exemplified by a focus on identifying and challenging
negative thoughts [30]. One study, based on the theory
of planned behavior, used a cardiovascular nurse to pro-
vide education and counseling for patients with congest-
ive heart failure; the self-efficacy component included
skills needed to overcome barriers to adherence [31].
Another study used tailored interactive voice response
technology to deliver a behavioral intervention based on
the health belief model, social cognitive theory, and self-
regulation theory to increase adherence to statin medica-
tion [32]. In this intervention, baseline patient measures
of knowledge and self-efficacy, in addition to other base-
line measures, were used to provide highly tailored feed-
back to study participants to enhance both knowledge
and self-efficacy. One study, based on protection motiv-
ation theory, was designed to influence both asthma
knowledge and asthma self-efficacy, as both have been
associated with adherence behavior [33].
Four studies were covered by the configuration “fG”;
these interventions did NOT have a facilitation compo-
nent but did include a motivational interviewing compo-
nent. The “fG” configuration uniquely covered two
studies. One of these studies evaluated the use of an au-
tomated telephone patient monitoring and counseling
approach on adherence to antihypertensive medication
and blood pressure control [34]. The motivational inter-
viewing component of this study was exemplified by use
of motivational counseling messages to improve adher-
ence. The other study uniquely covered by this configur-
ation included a software-based counseling intervention
provided by telephone by call center (nonclinical) staff
for improving adherence to a specific biological therapy
(interferon beta-1a) among patients with multiple scler-
osis [35]. The software-based counseling was based on
principles of motivational interviewing, as developed by
Miller and Rollnick [36]. The absence of a facilitation
component is exemplified by the automated or semiau-
tomated nature of both interventions, with the absence
of continuous professional support, individualizing of
regimens, and reducing environmental barriers to
adherence.
Two studies were uniquely covered by the “KRFICm”
configuration; these studies included components to in-
crease knowledge and awareness, provide facilitation,
and increase intention formation and use of action con-
trol but lacked a maintenance component. One study in-
volved nurse-led telephone encounters in the
Department of Veterans Affairs healthcare system using
computer-tailored feedback and home blood pressure
monitoring to improve adherence to both antihyperten-
sive regimens and lifestyle behaviors associated with bet-
ter blood pressure control [37]. The other study was an
intervention to prevent readmissions in elderly patients
with congestive heart failure [38]. This intervention was
mostly delivered face-to-face while patients were still in
the hospital, with some follow-up after discharge, using
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a teaching guide focused on diet and medication
adherence.
Three studies, all by the same author, were covered by
the “KrFT” configuration, which includes components to
increase knowledge, provide facilitation, and improve at-
titude, but does NOT include an awareness component.
These studies were similar in intervention design—two
were conducted in different populations of patients with
depression and diabetes [39, 40] and one study was in
patients with depression and hypertension [41]. These
studies used an integrated care manager to work with
patients and their physicians to individually address fac-
tors involved in adherence, based on a conceptual model
adapted from Cooper et al. [42].
Only one study was covered by the “kfCm” configur-
ation, which includes an action control component, but
does not include components to increase knowledge,
provide facilitation, or support maintenance. This study
consisted exclusively of daily, 3- to 5-min telephone or
video medication reminder calls by a research assistant
to community-dwelling patients over age 65 with con-
gestive heart failure [43]. This study exemplifies an ef-
fective intervention strategy, despite the absence of
components directed at increasing patient knowledge,
providing facilitation, or maintenance strategies.
Discussion
We identified seven different configurations of BCTs
that were sufficient for improving medication adherence
from a diverse body of evidence. In other words, when
one of these configurations is present within an inter-
vention, the intervention demonstrates improved adher-
ence. These configurations accounted for over three
quarters of studies demonstrating improved adherence.
Further, none of these configurations were identified as
sufficient for ineffective interventions. Although the con-
figuration of increasing knowledge AND enhancing self-
efficacy was the most empirically relevant, other suffi-
cient configurations offer alternative pathways to a suc-
cessful adherence intervention. The configuration
increasing knowledge and enhancing self-efficacy was
found predominantly among interventions targeting sin-
gle disease and applicability to adherence interventions
designed to target multiple conditions is not known.
Perhaps adherence interventions are simplest for staff to
implement and for patients to engage in when they in-
volve a single disease. These results generate some hy-
potheses about what works to improve adherence. These
findings could inform future adherence intervention de-
velopment and testing, specifically the development of
intervention features worth subjecting to rigorous com-
parative effectiveness evaluation.
Overall, we extended the results of the completed re-
view by using QCA to identify configurations of BCTs
across clinical conditions, intervention designs, and ap-
proaches. Using QCA allowed us to apply a logical
process to explore the empirical configurations of BCTs,
rather than deconstruct each study into its component
BCTs to determine the “net effect” of any one BCT on
the outcome of improved adherence. This approach can-
not replace a traditional qualitative or quantitative syn-
thesis, but it can complement findings by offering an
alternative approach for exploring heterogeneity among
interventions and its relationship to outcomes particu-
larly when assumptions required for quantitative
probabilistic exploration of heterogeneity (e.g., meta-
regression) cannot be met.
Beyond medication adherence interventions, the set-
theoretic lens offered by QCA assumes intervention
components and the context in which they are delivered
are not independent of each other and brings substantive
understanding and knowledge into the synthesis. The
use of QCA within systematic reviews is new, and we
are aware of only a few other applications in this context
[44, 45]. These examples are discussed in more detail in
our companion article [10].
In conducting the present study, we attempted to
apply as many standards of good practice for conducting
QCA as was feasible [11]. The greatest challenge we
faced was the lack of detail describing intervention com-
ponents in study publications. Consequently, we erred
on the conservative side by assuming that BCTs were
absent if it was unclear from the study description. This
may have underestimated the number of BCTs used
within a study, but we conducted sensitivity analyses as-
suming that these components were present and found
no substantive differences in the findings. In the future,
rigorous requirements for intervention description and
reporting, the availability of online supplemental mate-
rials, and the use of standard taxonomies for describing
and cataloging behavioral interventions may mitigate
some of the challenges we faced with respect to lack of
reported intervention detail.
Our study has several other limitations. Because of the
number of BCTs that we elected to include, we had lim-
ited diversity. We used some techniques to reduce the
number of included BCTs, such as eliminating infre-
quently used BCTs from the analysis. We also explored
the creation of macroconditions by combining single
BCTs into one set, but we found substantive experts
averse to the idea of coupling several distinct BCTs into
one set because of difficulties with interpretation.
Lastly, we used crisp-set calibration because data from
the completed review with respect to BCTs and out-
comes were abstracted dichotomously. However, this
may not reflect the continuum with which BCTs and the
outcome may have been represented within studies. The
outcome of improved adherence relied on whether at
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least one measure of adherence demonstrated a statisti-
cally significant improvement. The use of statistical sig-
nificance to determine which studies we deemed
“effective” for the QCA carries many of the limitations
of the use of statistical significance testing in general,
specifically findings due to chance in sampling, failing to
find significant effects because of studies that are under-
powered, or finding significant effects because of large
sample sizes, regardless of whether the magnitude of ef-
fect on adherence is clinically meaningful. Lastly, we
lacked external standards for establishing quantitative
differences in the use of BCTs or adherence outcomes
that would have allowed us to use fuzzy-set QCA, an ap-
proach that would have allowed more granular
distinctions.
Conclusions
We used a novel method within an existing systematic
review to identify several configurations of BCTs among
interventions to improve medication adherence in out-
patients on chronic medications. Interventions that in-
crease knowledge AND enhance self-efficacy are
sufficient for improving medication adherence; although
other configurations of BCTs can also be successful.
Using QCA, we were able to capitalize on the interven-
tion heterogeneity within an existing systematic review
to uncover patterns that would not have been identified
using traditional methods for qualitative or quantitative
synthesis. Our findings complement the results from the
existing review by offering options for practice or policy
and by generating hypotheses for future studies to evalu-
ate the comparative effectiveness and efficiency of differ-
ent approaches to improving adherence.
Additional file
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